{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T11:36:39Z","timestamp":1789472199638,"version":"build-2803163510"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,19]],"date-time":"2018-04-19T00:00:00Z","timestamp":1524096000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Key R&D Program of China","award":["2017YFC1001200"],"award-info":[{"award-number":["2017YFC1001200"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13048-018-0405-0","type":"journal-article","created":{"date-parts":[[2018,4,19]],"date-time":"2018-04-19T13:16:15Z","timestamp":1524143775000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Risk of synchronous endometrial disorders in women with endometrioid borderline tumors of the ovary"],"prefix":"10.1186","volume":"11","author":[{"given":"Shuang-zheng","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-ji","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-jun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-hua","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,19]]},"reference":[{"key":"405_CR1","doi-asserted-by":"publisher","first-page":"2928","DOI":"10.1200\/JCO.2007.10.8076","volume":"25","author":"I Cadron","year":"2007","unstructured":"Cadron I, Leunen K, Van Gorp T, Amant F, Neven P, Vergote I. Management of borderline ovarian neoplasms. J Clin Oncol. 2007;25:2928\u201337.","journal-title":"J Clin Oncol"},{"key":"405_CR2","first-page":"29","volume-title":"WHO classification of Tumours of female reproductive organs","author":"LH Ellenson","year":"2014","unstructured":"Ellenson LH, Carinelli SG, Cho KR, Kim KR, Kupryjanczyk J, Prat J, et al. Endometrioid tumours. In: Kurman RJ, Carcangiu ML, Herrington CS, Young RH, editors. WHO classification of Tumours of female reproductive organs. Lyon: IARC; 2014. p. 29\u201332."},{"key":"405_CR3","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1093\/annonc\/mdu139","volume":"25","author":"C Uzan","year":"2014","unstructured":"Uzan C, Nikpayam M, Ribassin-Majed L, Gouy S, Bendifallah S, Cortez A, et al. Influence of histological subtypes on the risk of an invasive recurrence in a large series of stage I borderline ovarian tumor including 191 conservative treatments. Ann Oncol. 2014;25:1312\u20139.","journal-title":"Ann Oncol"},{"key":"405_CR4","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1093\/humupd\/dms047","volume":"19","author":"E Darai","year":"2013","unstructured":"Darai E, Fauvet R, Uzan C, Gouy S, Duvillard P, Morice P. Fertility and borderline ovarian tumor: a systematic review of conservative management, risk of recurrence and alternative options. Hum Reprod Update. 2013;19:151\u201366.","journal-title":"Hum Reprod Update"},{"key":"405_CR5","doi-asserted-by":"publisher","first-page":"e103","DOI":"10.1016\/S1470-2045(11)70288-1","volume":"13","author":"P Morice","year":"2012","unstructured":"Morice P, Uzan C, Fauvet R, Gouy S, Duvillard P, Darai E. Borderline ovarian tumour: pathological diagnostic dilemma and risk factors for invasive or lethal recurrence. Lancet Oncol. 2012;13:e103\u201315.","journal-title":"Lancet Oncol"},{"key":"405_CR6","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.suronc.2012.02.002","volume":"21","author":"C Uzan","year":"2012","unstructured":"Uzan C, Berretta R, Rolla M, Gouy S, Fauvet R, Darai E, et al. Management and prognosis of endometrioid borderline tumors of the ovary. Surg Oncol. 2012;21:178\u201384.","journal-title":"Surg Oncol"},{"key":"405_CR7","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1097\/00000478-200011000-00002","volume":"24","author":"KA Bell","year":"2000","unstructured":"Bell KA, Kurman RJ. A clinicopathologic analysis of atypical proliferative (borderline) tumors and well-differentiated endometrioid adenocarcinomas of the ovary. Am J Surg Pathol. 2000;24:1465\u201379.","journal-title":"Am J Surg Pathol"},{"key":"405_CR8","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/00000478-198503000-00004","volume":"9","author":"DA Bell","year":"1985","unstructured":"Bell DA, Scully RE. Atypical and borderline endometrioid adenofibromas of the ovary. A report of 27 cases. Am J Surg Pathol. 1985;9:205\u201314.","journal-title":"Am J Surg Pathol"},{"key":"405_CR9","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1097\/00000478-198809000-00002","volume":"12","author":"RR Snyder","year":"1988","unstructured":"Snyder RR, Norris HJ, Tavassoli F. Endometrioid proliferative and low malignant potential tumors of the ovary. A clinicopathologic study of 46 cases. Am J Surg Pathol. 1988;12:661\u201371.","journal-title":"Am J Surg Pathol"},{"key":"405_CR10","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1097\/00000478-200309000-00009","volume":"27","author":"LM Roth","year":"2003","unstructured":"Roth LM, Emerson RE, Ulbright TM. Ovarian endometrioid tumors of low malignant potential: a clinicopathologic study of 30 cases with comparison to well-differentiated endometrioid adenocarcinoma. Am J Surg Pathol. 2003;27:1253\u20139.","journal-title":"Am J Surg Pathol"},{"key":"405_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijgo.2013.10.001","volume":"124","author":"J Prat","year":"2014","unstructured":"Prat J. Staging classification for cancer of the ovary, fallopian tube, and peritoneum. Int J Gynecol Obstet. 2014;124:1\u20135.","journal-title":"Int J Gynecol Obstet"},{"key":"405_CR12","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1097\/IGC.0000000000000282","volume":"24","author":"P Harter","year":"2014","unstructured":"Harter P, Gershenson D, Lhomme C, Lecuru F, Ledermann J, Provencher DM, et al. Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian tumors of low malignant potential (borderline ovarian tumors). Int J Gynecol Cancer. 2014;24:S5\u20138.","journal-title":"Int J Gynecol Cancer"},{"key":"405_CR13","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.humpath.2011.03.003","volume":"42","author":"RJ Kurman","year":"2011","unstructured":"Kurman RJ, Shih I. Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm. Hum Pathol. 2011;42:918\u201331.","journal-title":"Hum Pathol"},{"key":"405_CR14","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.ygyno.2004.05.006","volume":"94","author":"PT Soliman","year":"2004","unstructured":"Soliman PT, Slomovitz BM, Broaddus RR, Sun CC, Oh JC, Eifel PJ, et al. Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases. Gynecol Oncol. 2004;94:456\u201362.","journal-title":"Gynecol Oncol"},{"key":"405_CR15","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/1471-0528.14385","volume":"124","author":"ME Pennant","year":"2017","unstructured":"Pennant ME, Mehta R, Moody P, Hackett G, Prentice A, Sharp SJ, et al. Premenopausal abnormal uterine bleeding and risk of endometrial cancer. BJOG. 2017;124:404\u201311.","journal-title":"BJOG"},{"key":"405_CR16","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s00404-009-1290-y","volume":"282","author":"S Ozdemir","year":"2010","unstructured":"Ozdemir S, Celik C, Gezginc K, Kiresi D, Esen H. Evaluation of endometrial thickness with transvaginal ultrasonography and histopathology in premenopausal women with abnormal vaginal bleeding. Arch Gynecol Obstet. 2010;282:395\u20139.","journal-title":"Arch Gynecol Obstet"},{"key":"405_CR17","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/1097-0142(19820701)50:1<163::AID-CNCR2820500131>3.0.CO;2-K","volume":"50","author":"P Eifel","year":"1982","unstructured":"Eifel P, Hendrickson M, Ross J, Ballon S, Martinez A, Kempson R. Simultaneous presentation of carcinoma involving the ovary and the uterine corpus. Cancer. 1982;50:163\u201370.","journal-title":"Cancer"},{"key":"405_CR18","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S1047-2797(01)00237-X","volume":"11","author":"LJ Herrinton","year":"2001","unstructured":"Herrinton LJ, Voigt LF, Weiss NS, Beresford SA, Wingo PA. Risk factors for synchronous primary endometrial and ovarian cancers. Ann Epidemiol. 2001;11:529\u201333.","journal-title":"Ann Epidemiol"},{"key":"405_CR19","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.prp.2008.02.001","volume":"204","author":"A Caldarella","year":"2008","unstructured":"Caldarella A, Crocetti E, Taddei GL, Paci E. Coexisting endometrial and ovarian carcinomas: a retrospective clinicopathological study. Pathol Res Pract. 2008;204:643\u20138.","journal-title":"Pathol Res Pract"},{"key":"405_CR20","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.ygyno.2016.06.014","volume":"142","author":"V Giannakeas","year":"2016","unstructured":"Giannakeas V, Sopik V, Narod SA. A model for ovarian cancer progression based on inherent resistance. Gynecol Oncol. 2016;142:484\u20139.","journal-title":"Gynecol Oncol"},{"key":"405_CR21","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.gore.2016.09.004","volume":"18","author":"AS Lagan\u00e0","year":"2016","unstructured":"Lagan\u00e0 AS, Sofo V, Vitale SG, Triolo O. Epithelial ovarian cancer inherent resistance: may the pleiotropic interaction between reduced immunosurveillance and drug-resistant cells play a key role? Gynecologic Oncology Reports. 2016;18:57\u20138.","journal-title":"Gynecologic Oncology Reports"},{"key":"405_CR22","doi-asserted-by":"publisher","first-page":"4118","DOI":"10.1002\/cncr.24461","volume":"115","author":"JD Wright","year":"2009","unstructured":"Wright JD, Shah M, Mathew L, Burke WM, Culhane J, Goldman N, et al. Fertility preservation in young women with epithelial ovarian cancer. Cancer. 2009;115:4118\u201326.","journal-title":"Cancer"},{"key":"405_CR23","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3802\/jgo.2009.20.1.44","volume":"20","author":"YS Kwon","year":"2009","unstructured":"Kwon YS, Hahn HS, Kim TJ, Lee IH, Lim KT, Lee KH, et al. Fertility preservation in patients with early epithelial ovarian cancer. J Gynecol Oncol. 2009;20:44\u20137.","journal-title":"J Gynecol Oncol"},{"key":"405_CR24","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1080\/14647273.2017.1339365","volume":"21","author":"SG Vitale","year":"2018","unstructured":"Vitale SG, Rosa VLL, Rapisarda AMC, Lagan\u00e0 AS. Fertility preservation in women with gynaecologic cancer: the impact on quality of life and psychological well-being. Hum Fertil. 2018;21:35\u20138.","journal-title":"Hum Fertil"},{"key":"405_CR25","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1093\/annonc\/mdp267","volume":"21","author":"C Uzan","year":"2010","unstructured":"Uzan C, Kane A, Rey A, Gouy S, Duvillard P, Morice P. Outcomes after conservative treatment of advanced-stage serous borderline tumors of the ovary. Ann Oncol. 2010;21:55\u201360.","journal-title":"Ann Oncol"},{"key":"405_CR26","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1093\/humrep\/deq159","volume":"25","author":"S Palomba","year":"2010","unstructured":"Palomba S, Falbo A, Del NS, Rocca M, Russo T, Cariati F, et al. Ultra-conservative fertility-sparing strategy for bilateral borderline ovarian tumours: an 11-year follow-up. Hum Reprod. 2010;25:1966\u201372.","journal-title":"Hum Reprod"},{"key":"405_CR27","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1007\/s00404-010-1804-7","volume":"284","author":"M Kanat-Pektas","year":"2011","unstructured":"Kanat-Pektas M, Ozat M, Gungor T, Dikici T, Yilmaz B, Mollamahmutoglu L. Fertility outcome after conservative surgery for borderline ovarian tumors: a single center experience. Arch Gynecol Obstet. 2011;284:1253\u20138.","journal-title":"Arch Gynecol Obstet"},{"key":"405_CR28","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1245\/s10434-011-2039-y","volume":"19","author":"R Fauvet","year":"2012","unstructured":"Fauvet R, Demblocque E, Morice P, Querleu D, Darai E. Behavior of serous borderline ovarian tumors with and without micropapillary patterns: results of a French multicenter study. Ann Surg Oncol. 2012;19:941\u20137.","journal-title":"Ann Surg Oncol"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-018-0405-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13048-018-0405-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-018-0405-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,18]],"date-time":"2019-04-18T23:26:13Z","timestamp":1555629973000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-018-0405-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,19]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["405"],"URL":"https:\/\/doi.org\/10.1186\/s13048-018-0405-0","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,19]]},"assertion":[{"value":"11 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Institutional Review Board at the Peking Union Medical College Hospital approved the study (approval No. S-K351). Verbal informed consent was obtained from all patients at their follow-up interviews, and the study was conducted in accordance with the Declaration of Helsinki Principles and regulations of our institute.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"30"}}